PUBLISHER: The Business Research Company | PRODUCT CODE: 1889501
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889501
Lyme Disease Vaccine Global Market Report 2025
Lyme disease vaccines are biological preparations developed to stimulate the immune system to identify and combat Borrelia burgdorferi, the bacteria that cause Lyme disease, thereby preventing infection after a tick bite. These vaccines function by prompting the body to produce specific antibodies that neutralize the bacteria, lowering the likelihood of disease transmission and related complications, and serving as an important tool for controlling Lyme disease in regions where it is common.
The key vaccine types for Lyme disease include recombinant vaccines, subunit vaccines, live attenuated vaccines, and others. Recombinant vaccines are created using genetic engineering methods to generate specific proteins (antigens) from Borrelia burgdorferi, the bacteria responsible for Lyme disease. They employ various technologies such as the lymphocytic transformation test, urine antigen testing, immunofluorescent staining, nucleic acid testing, and serological testing, and are intended for age groups including pediatric, adult, and geriatric populations. Distribution channels include hospitals and clinics, pharmacies, government supply, and others, serving end users such as hospitals, clinical laboratories, and additional healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The Lyme disease vaccine market research report is one of a series of new reports from The Business Research Company that provides Lyme disease vaccine market statistics, including Lyme disease vaccine industry global market size, regional shares, competitors with a Lyme disease vaccine market share, detailed Lyme disease vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the Lyme disease vaccine industry. This Lyme disease vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The Lyme disease vaccine market size has grown strongly in recent years. It will grow from $1.04 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period resulted from growing human-tick interaction due to habitat expansion, rising healthcare infrastructure in endemic regions, increasing research funding for infectious-disease vaccines, and greater consumer interest in preventive travel or occupational health.
The Lyme disease vaccine market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period will be driven by the rising incidence of Lyme disease, growing public health awareness of tick-borne risks, increasing government investment in vaccine development, rising demand for preventive vector-borne disease solutions, and expanding collaboration in biotech for vaccine platforms. Major trends in the forecast period include technological advancements in mRNA and recombinant Lyme vaccines, the integration of Lyme vaccination into routine immunization programs, innovations in multi-pathogen tick-borne disease vaccines, collaborative global vaccine development partnerships, and progress in novel delivery systems.
The growing prevalence of Lyme disease is expected to drive the expansion of the Lyme disease vaccine market in the future. Lyme disease is a tick-borne illness caused by Borrelia bacteria, which can lead to symptoms such as fever, fatigue, rashes, and, if left untreated, severe complications affecting the joints, heart, or nervous system. The rise in Lyme disease cases is largely attributed to climate change, as warmer temperatures and milder winters are expanding tick habitats, thereby increasing human exposure to infected ticks. Lyme disease vaccines help prevent the infection by stimulating the immune system to recognize and fight off Borrelia bacteria, thereby reducing the risk of disease. These vaccines offer long-term protection, which contributes to better public health outcomes. For example, the Centers for Disease Control and Prevention (CDC) reported that in 2023, approximately 89,000 cases of Lyme disease were officially recorded in the U.S., although estimates suggest that nearly 476,000 people may be diagnosed and treated for the disease annually. Thus, the rising prevalence of Lyme disease is fueling the growth of the Lyme disease vaccine market.
Rising healthcare expenditure is also expected to drive growth in the Lyme disease vaccine market. Healthcare expenditure refers to the total amount of financial resources allocated to medical services, treatments, facilities, research, and public health initiatives aimed at improving or maintaining health. The increasing demand for healthcare services is driven by the rising prevalence of chronic diseases that require long-term, costly treatments. The growth in healthcare spending supports the development of Lyme disease vaccines by providing additional funding for research, clinical trials, and production processes. This facilitates the advancement of vaccine technologies, improving both accessibility and effectiveness for high-risk populations. For example, in May 2024, the Office for National Statistics reported that healthcare expenditure in the UK increased by 5.6% in nominal terms in 2023, marking a 0.9% rise from 2022. Consequently, the rise in healthcare expenditure is contributing to the growth of the Lyme disease vaccine market.
Leading companies in the Lyme disease vaccine market are focusing on advancing their late-stage product candidates, including booster vaccines, to meet unmet medical needs, improve immune protection, and streamline vaccination schedules. Booster vaccines are additional doses given after the initial vaccination to enhance or restore long-term immunity. For example, in September 2025, Valneva SE, a France-based biotechnology firm, reported positive results from a Phase 2 study of its Lyme disease vaccine candidate, VLA15. This multivalent vaccine targets OspA proteins on Borrelia bacteria, triggering the immune system to produce antibodies that block bacterial infection when ticks bite. The study demonstrated a strong immune response and a favorable safety profile following a third booster dose, with results consistent with those seen after previous annual booster shots. This suggests that the vaccine can provide continued protection against Lyme disease, with the potential for a yearly pre-exposure booster dose before each Lyme season, making vaccination easier for at-risk individuals.
Major companies operating in the lyme disease vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Boehringer Ingelheim GmbH, University of Pennsylvania, Elanco Animal Health Incorporated, Elanco Animal Health Incorporated, Zoetis Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Life Inc., Bioveta a.s., Dynavax Technologies Corporation, Valneva SE, MassBiologics of UMass Chan Medical School, Inovio Pharmaceuticals Inc., US Biologic Inc., Blue Lake Biotechnology Inc.
North America was the largest region in the Lyme disease vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in Lyme disease vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Lyme disease vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The Lyme disease vaccine market consists of sales of pre-filled syringes, single or multi-dose vials, vaccine kits, storage and delivery equipment, and cold-chain packaging materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lyme Disease Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lyme disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lyme disease vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Vaccine Type: Recombinant Vaccines; Subunit Vaccines; Live Attenuated Vaccines; Other Vaccine Types
- 2) By Technology: Lymphocytic Transformation Test; Urine Antigen Testing; Immunofluorescent Staining Nucleic Acid Test; Serological Test
- 3) By Age Group: Pediatric; Adult; Geriatric
- 4) By Distribution Channel: Hospitals And Clinics; Pharmacies; Government Supply; Other Distribution Channels
- 5) By End User: Hospitals; Clinical Laboratories; Other End Users
- Subsegments:
- 1) By Recombinant Vaccines: Protein-Based Recombinant Vaccines; Vector-Based Recombinant Vaccines; Deoxyribonucleic Acid (DNA)-Based Recombinant Vaccines
- 2) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines; Conjugate Subunit Vaccines
- 3) By Live Attenuated Vaccines: Naturally Attenuated Vaccines; Genetically Attenuated Vaccines; Temperature-Sensitive Attenuated Vaccines
- 4) By Other Vaccine Types: Toxoid Vaccines; Inactivated Vaccines; Vectored Vaccines
- Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; Boehringer Ingelheim GmbH; University of Pennsylvania; Elanco Animal Health Incorporated; Elanco Animal Health Incorporated; Zoetis Inc.; Emergent BioSolutions Inc.; Bavarian Nordic A/S; Aegis Life Inc.; Bioveta a.s.; Dynavax Technologies Corporation; Valneva SE; MassBiologics of UMass Chan Medical School; Inovio Pharmaceuticals Inc.; US Biologic Inc.; Blue Lake Biotechnology Inc.
- Countries:
Table of Contents
1. Executive Summary
2. Lyme Disease Vaccine Market Characteristics
3. Lyme Disease Vaccine Market Trends And Strategies
4. Lyme Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Lyme Disease Vaccine Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lyme Disease Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lyme Disease Vaccine Market Growth Rate Analysis
- 5.4. Global Lyme Disease Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lyme Disease Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lyme Disease Vaccine Total Addressable Market (TAM)
6. Lyme Disease Vaccine Market Segmentation
- 6.1. Global Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Recombinant Vaccines
- Subunit Vaccines
- Live Attenuated Vaccines
- Other Vaccine Types
- 6.2. Global Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lymphocytic Transformation Test
- Urine Antigen Testing
- Immunofluorescent Staining Nucleic Acid Test
- Serological Test
- 6.3. Global Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- Geriatric
- 6.4. Global Lyme Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Pharmacies
- Government Supply
- Other Distribution Channels
- 6.5. Global Lyme Disease Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinical Laboratories
- Other End Users
- 6.6. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein-Based Recombinant Vaccines
- Vector-Based Recombinant Vaccines
- Deoxyribonucleic Acid (DNA)-Based Recombinant Vaccines
- 6.7. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein Subunit Vaccines
- Polysaccharide Subunit Vaccines
- Conjugate Subunit Vaccines
- 6.8. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Naturally Attenuated Vaccines
- Genetically Attenuated Vaccines
- Temperature-Sensitive Attenuated Vaccines
- 6.9. Global Lyme Disease Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Toxoid Vaccines
- Inactivated Vaccines
- Vectored Vaccines
7. Lyme Disease Vaccine Market Regional And Country Analysis
- 7.1. Global Lyme Disease Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lyme Disease Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lyme Disease Vaccine Market
- 8.1. Asia-Pacific Lyme Disease Vaccine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lyme Disease Vaccine Market
- 9.1. China Lyme Disease Vaccine Market Overview
- 9.2. China Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lyme Disease Vaccine Market
- 10.1. India Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lyme Disease Vaccine Market
- 11.1. Japan Lyme Disease Vaccine Market Overview
- 11.2. Japan Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lyme Disease Vaccine Market
- 12.1. Australia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lyme Disease Vaccine Market
- 13.1. Indonesia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lyme Disease Vaccine Market
- 14.1. South Korea Lyme Disease Vaccine Market Overview
- 14.2. South Korea Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lyme Disease Vaccine Market
- 15.1. Western Europe Lyme Disease Vaccine Market Overview
- 15.2. Western Europe Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lyme Disease Vaccine Market
- 16.1. UK Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lyme Disease Vaccine Market
- 17.1. Germany Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lyme Disease Vaccine Market
- 18.1. France Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lyme Disease Vaccine Market
- 19.1. Italy Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lyme Disease Vaccine Market
- 20.1. Spain Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lyme Disease Vaccine Market
- 21.1. Eastern Europe Lyme Disease Vaccine Market Overview
- 21.2. Eastern Europe Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lyme Disease Vaccine Market
- 22.1. Russia Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lyme Disease Vaccine Market
- 23.1. North America Lyme Disease Vaccine Market Overview
- 23.2. North America Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lyme Disease Vaccine Market
- 24.1. USA Lyme Disease Vaccine Market Overview
- 24.2. USA Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lyme Disease Vaccine Market
- 25.1. Canada Lyme Disease Vaccine Market Overview
- 25.2. Canada Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lyme Disease Vaccine Market
- 26.1. South America Lyme Disease Vaccine Market Overview
- 26.2. South America Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lyme Disease Vaccine Market
- 27.1. Brazil Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lyme Disease Vaccine Market
- 28.1. Middle East Lyme Disease Vaccine Market Overview
- 28.2. Middle East Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lyme Disease Vaccine Market
- 29.1. Africa Lyme Disease Vaccine Market Overview
- 29.2. Africa Lyme Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lyme Disease Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lyme Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lyme Disease Vaccine Market Competitive Landscape And Company Profiles
- 30.1. Lyme Disease Vaccine Market Competitive Landscape
- 30.2. Lyme Disease Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. University of Pennsylvania Overview, Products and Services, Strategy and Financial Analysis
31. Lyme Disease Vaccine Market Other Major And Innovative Companies
- 31.1. Elanco Animal Health Incorporated
- 31.2. Elanco Animal Health Incorporated
- 31.3. Zoetis Inc.
- 31.4. Emergent BioSolutions Inc.
- 31.5. Bavarian Nordic A/S
- 31.6. Aegis Life Inc.
- 31.7. Bioveta a.s.
- 31.8. Dynavax Technologies Corporation
- 31.9. Valneva SE
- 31.10. MassBiologics of UMass Chan Medical School
- 31.11. Inovio Pharmaceuticals Inc.
- 31.12. US Biologic Inc.
- 31.13. Blue Lake Biotechnology Inc.
32. Global Lyme Disease Vaccine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lyme Disease Vaccine Market
34. Recent Developments In The Lyme Disease Vaccine Market
35. Lyme Disease Vaccine Market High Potential Countries, Segments and Strategies
- 35.1 Lyme Disease Vaccine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lyme Disease Vaccine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lyme Disease Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
